Page 73 - 《中国药科大学学报》2026年第1期

第 57 卷第 1 期 王俪颖，等：Isthmin-1 通过调控 FoxO 信号通路抑制非小细胞肺癌细胞生长的研究 67

[9] Chen M, Zhang Y, Yu VC, et al. Isthmin targets cell-surface candidate in lung cancer[J]. Biomed Pharmacother, 2023, 169:
GRP78 and triggers apoptosis via induction of mitochondrial 115900.
dysfunction[J]. Cell Death Differ, 2014, 21(5): 797-810. [17] Ebrahimnezhad M, Valizadeh A, Majidinia M, et al. Unveiling
[10] Zhang Y, Chen M, Venugopal S, et al. Isthmin exerts pro-sur- the potential of FOXO3 in lung cancer: from molecular insights
vival and death-promoting effect on endothelial cells through al- to therapeutic prospects[J]. Biomed Pharmacother, 2024, 176:
phavbeta5 integrin depending on its physical state[J]. Cell 116833.
Death Dis, 2011, 2(5): e153. [18] Li MH, Yang Y, Ma QH, et al. Advances in research of biologi-
[11] Liang JY, Wei HJ, Tang YY. Isthmin: a multifunctional secre- cal functions of isthmin-1[J]. J Cell Commun Signal, 2023,
tion protein[J]. Cytokine, 2024, 173: 156423. 17(3): 507-521.
[12] Yuan BQ, Xian RH, Ma JF, et al. Isthmin inhibits glioma [19] Jiang ZW, Zhao M, Voilquin L, et al. Isthmin-1 is an adipokine
growth through antiangiogenesis in vivo[J]. J Neurooncol, 2012, that promotes glucose uptake and improves glucose tolerance
109(2): 245-252. and hepatic steatosis[J]. Cell Metab, 2021, 33(9): 1836-1852.
[13] Turk A, Metin TO, Kuloglu T, et al. Isthmin-1 and spexin as [20] Kao C, Chandna R, Ghode A, et al. Proapoptotic cyclic peptide
promising novel biomarker candidates for invasive ductal breast BC71 targets cell-surface GRP78 and functions as an anti-
carcinoma[J]. Tissue Cell, 2024, 91: 102601. cancer therapeutic in mice[J]. EBioMedicine, 2018, 33: 22-32.
[14] Zheng YS, Zheng YT, Lei WD, et al. miR-1307-3p overexpres- [21] Lam TYW, Nguyen N, Peh HY, et al. ISM1 protects lung
sion inhibits cell proliferation and promotes cell apoptosis by homeostasis via cell-surface GRP78-mediated alveolar
targeting ISM1 in colon cancer[J]. Mol Cell Probes, 2019, 48: macrophage apoptosis[J]. Proc Natl Acad Sci USA, 2022,
101445. 119(4): e2019161119.
[15] Zhou X, Zhang KN, Wang C, et al. Isthmin-1 promotes growth [22] Wu YH, Liang XJ, Ni JJ, et al. Effect of ISM1 on the immune
and progression of colorectal cancer through the interaction microenvironment and epithelial-mesenchymal transition in col-
with EGFR and YBX-1[J]. Cancer Lett, 2024, 590: 216868. orectal cancer[J]. Front Cell Dev Biol, 2021, 9: 681240.
[16] Ebrahimnezhad M, Natami M, Bakhtiari GH, et al. FOXO1, a [23] Chen X, Zhu LJ, Ma Z, et al. Oncogenic miR-9 is a target of er-
tiny protein with intricate interactions: promising therapeutic lotinib in NSCLCs[J]. Sci Rep, 2015, 5: 17031.